Synovasure® Alpha DefensinÌý Lateral Flow Test Ìý
When You Need to Know Now
The first of its kind, theÌýSynovasure Alpha Defensin Lateral Flow Test is specifically designedÌýas an aid for the diagnosis ofÌýperiprostheticÌýjoint infection (PJI). The test delivers same day results with speed and accuracy.1Ìý
Procedures
- Infection Diagnostics
Application
- Revision KneeÌý
- Revision Hip
The Synovasure Alpha Defensin Lateral Flow Test offers a rapid and accurate positive/negative result (10 minutes) to aid in diagnosis of PJI.
Ìý -
94.3%vs. sensitivity standard of care criteria1
.
94.5%vs. specificity standard of care criteria1*
* Excluding samples with >20% blood
Product Features
The Synovasure Alpha Defensin Lateral Flow Test is a standalone, rapid device for detecting alpha defensin in synovial fluid. The test received FDA authorization in 2019 as a CLIA moderately complex test.
Ìý
Same-Day Results
Results in 10 minutes following performance of test
Ìý
Performance Backed by Data
Demonstrates a high sensitivity (94.3%) and specificity (94.5%). In addition, results proven in clinical studies to be unaffected by:
- Prior antibiotic administration1,3,4
- Comorbidities related to inflammation1,3,5
- Type and/or virulence of the organism1,3,6
Ìý
Minimal Fluid Requirement
Only needs 15 microliters of synovial fluid to perform test
Ìý
Consistent results to Laboratory Test
No statistically significant difference in performance of Synovasure Alpha Defensin Lateral Flow Test and Synovasure Alpha Defensin ELISA laboratory test.1
Brochure and Resources
Literature
Videos
Synvosure Alpha Defensin Lateral Flow Test
Watch animation
Synovasure Alpha Defensin Control Kit – How to Use
Watch animation
What is Alpha Defensin
Watch animation
Synovasure Diagnostics Product Offerings
Watch animation
Additional Information
Related Products
Legal Disclaimer
All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to 91ÖÆƬ³§ or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of 91ÖÆƬ³§.  Ìý
This material is intended for health care professionals. Distribution to any other recipient is prohibited.Ìý
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see theÌýinstructions for use or contact your local representative; search this website for additional product information.ÌýTo obtain a copy of the current Instructions for Use (IFU) for full prescribing and risk information, please visit .ÌýFor product related questions, please call 1-800-348-2759.Ìý